consenso cripto

at 2 hospitals in Washington, DC: adherence of health care providers 
to published practice guidelines for the management of cryptococcal disease. 
Clinical of Infectious Diseases 40: 477-479, 2005.
103. Shoham S, Levitz SM. The immune response to fungal infections. British Journal 
of Hematology 129: 569-582, 2005. 
104. Singh N, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, del Busto R, 
Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Muñoz P, Limaye AP, 
Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, 
Orloff S, Dowdy LA, Fisher RA, Heitman J, Wagener MM, Husain S. Pulmonary 
cryptococcosis in solid organ transplant recipients: clinical relevance of serum 
cryptococcal antigen. Clinical of Infectious Diseases 46: 12-18, 2008.
105. Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell K, Munoz 
P, Klintmalm GB, Stosor V, del Busto R, Limaye AP, Somani J, Lyon M, 
Houston S, House AA, Pruett TL, Orloff S, Humar A, Dowdy L, Garcia-Diaz J, 
Kalil AC, Fisher RA, Husain S; Cryptococcal Collaborative Transplant Study Group. 
An immune reconstitution syndrome-like illness associated with Cryptococcus
neoformans infection in organ transplant recipients. Clinical of Infectious 
Diseases 40: 1756-1761, 2005.
106. Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell KJ, Muñoz 
P, Klintmalm GB, Stosor V, Del Busto R, Limaye AP, Somani J, Lyon M, 
Houston S, House AA, Pruett TL, Orloff S, Humar A, Dowdy LA, Garcia-Diaz J, 
Kalil AC, Fisher RA, Heitman J, Husain S. Antifungal management practices 
and evolution of infection in organ transplant recipients with Cryptococcus 
neoformans infection. Transplantation 80: 1033-1039, 2005.
107. Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell K, Munoz P, 
Klintmalm GB, Stosor V, Del Busto R, Limaye AP, Somani J, Lyon M, Houston S, 
House AA, Pruett TL, Orloff S, Humar A, Dowdy L, Garcia-Diaz J, Fisher RA, 
Husain S, Cryptococcal Collaborative Transplant Study Group. Allograft loss in 
renal transplant recipients with Cryptococcus neoformans associated immune 
reconstitution syndrome. Transplantation 80:1131-1133, 2005
108. Staib F, Seibold M, L´age M, Heise W, Skörde J, Grosse G, Nürnberger F, 
Bauer G. Cryptococcus neoformans in the seminal fluid of an AIDS patient. 
A contribution to the clinical course of cryptococcosis. Mycoses 32:171-180, 
1989.
109. Stamm AM, Diasio RB, Dismukes WE, Shadomy S, Cloud GA, Bowles CA, Karam GH, 
Espinel-Ingroff A.Toxicity of amphotericin B plus flucytosine in 194 patients with 
cryptococcal meningitis. American Journal of Medicine 83:236-242, 1987. 
110. Swinne D, De Vroey C. Detection of circulating capsular polysaccharide antigen 
from Cryptococcus neoformans. Journal of Clinical Microbiology 30:2521, 
1992.
111. Swinne D, Deppner M, Laroche R, Floch JJ, Kadende P. Isolation of Cryptococcus 
neoformans from houses of AIDS-associated cryptococcosis patients in 
Bujumbura (Burundi). AIDS 3: 389-390, 1989.
112. Swinne D, Nkurikiyinfura JB, Muyembe TL. Clinical isolates of Cryptococcus
neoformans from Zaire. European Journal Clinical Microbiology 5: 50-51, 
1986.
113. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, 
Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE. 
The National Institute of Allergy and Infectious Diseases Mycoses Study Group 
and AIDS Clinical Trials Group. Treatment of cryptococcal meningitis associated 
with acquired immunodeficiency syndrome. New England of Journal Medicine 
337:15-21, 1997. 
114. Venkataramanan R, Zang S, Gayowski T, Singh N. Voriconazole inhibition of 
the metabolism of tacrolimus in a liver transplant recipient and in human liver 
microsomes. Antimicrobial Agents and Chemotherapy 46: 3091-3093, 2002.
115. Verma N, Kearney J. Ocular manifestations of AIDS. Papua and New Guinea Medical 
Journal 39:196-199, 1996. 
116. Vibhagool A, Sungkanuparph S, Mootsikapun P, Chetchotisakd P, 
Tansuphaswaswadikul S, Bowonwatanuwong C, Ingsathit A. Discontinuation of 
secondary prophylaxis for cryptococcal meningitis in human immunodeficiency 
virus-infected patients treated with highly active antiretroviral therapy: a 
prospective, multicenter, randomized study. Clinical of Infectious Diseases 
36:1329-1331, 2003.
117. Vilchez R, Shapiro R, McCurry K, Kormos R, Abu-Elmagd K, Fung J, Kusne S. 
Longitudinal study of cryptococcosis in adult solid-organ transplant recipients.
Transplant International 16: 336-340, 2003. 
118. Vilchez RA, Fung J, Kusne S. Cryptococcosis in organ transplant recipients: 
an overview. American Journal of Transplantation 2:575-580, 2002. 
119. Vilchez RA, Irish W, Lacomis J, Costello P, Fung J, Kusne S. The clinical 
epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary 
care medical center. Medicine 80: 308-312, 2001 
120. Wu G, Vilchez RA, Eidelman B, Fung J, Kormos R, Kusne S.Cryptococcal meningitis: 
an analysis among 5,521 consecutive organ transplant recipients. Transplantation 
Infectious Diseases. 4: 183-188, 2002.
121. Yao Z, Liao W, Chen R. Management of cryptococcosis in non-HIV related patients. 
Medical Mycology 43:245-251, 2005.
Revista da Sociedade Brasileira de Medicina Tropical 41(5):524-544, set-out, 2008